Blood Collection Market is expected to grow at a CAGR of 5.24% during the forecasted period | Evolve Business Intelligence

Key Highlights:
• The global Blood Collection market size is expected to reach $7.58 Billion in 2023 growing at a CAGR of 5.24% from 2023 to 2033.
• North America dominated the market in 2023
• Asia Pacific is expected to grow at the highest CAGR from 2023 to 2033

As per the study initiated by Evolve Business Intelligence, The global Blood Collection market size is expected to reach $7.58 Billion in 2023 growing at a CAGR of 5.24% from 2023 to 2033. Blood collection refers to the process of withdrawing blood from a person's body, typically for medical testing, diagnostic purposes, blood donation, or therapeutic interventions. This procedure is performed by healthcare professionals using various techniques, such as venipuncture (drawing blood from a vein) or capillary puncture (obtaining blood from a small skin prick). The collected blood is then often analyzed in laboratories to assess various health parameters, including blood cell counts, cholesterol levels, glucose levels, and the presence of infectious agents. Proper blood collection is crucial for accurate and reliable diagnostic results and is a routine aspect of medical care and research.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021713

The Blood Collection market is primarily driven by the increasing demand for diagnostic testing, the rising prevalence of chronic diseases, and the expanding healthcare infrastructure, fostering the need for efficient and safe blood collection products and services globally.

Key Players
Some of the major Blood Collection Market players holding high market shares include Medtronic, Inc., Abbott Laboratories Inc., F.L. Medical SRL, Nipro Medical Corporation, and Greiner Holding AG. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include Qiagen NV, Haemonetics Corporation, Becton Dickinson and Company, Sarstedt AG, and Terumo Corporation.

Report Description: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021713

Segmental Analysis
Based on the Product Type, the Blood Collection market is segmented into Needles and Syringes, Blood Collection Tubes, Blood Lancets, Blood Bags, and Others. The dominance of the Needles and Syringes segment in the Blood Collection market is attributed to its widespread use for venipuncture, providing a reliable and efficient means for collecting blood samples in various healthcare settings, including clinics and laboratories.
Based on the Application, the Blood Collection market is segmented into Diagnostics and treatment. The dominance of the Diagnostics segment in the Blood Collection market is driven by the increasing demand for diagnostic tests, routine health screenings, and disease monitoring, highlighting the pivotal role of blood collection in providing essential biological samples for accurate medical diagnoses and patient care.
Based on the End User, the Blood Collection market is segmented into Hospitals and Diagnostic Centers, Blood Banks, and Others. The dominance of the Hospitals and Diagnostic Centers segment in the Blood Collection market is attributed to the central role these facilities play in healthcare, conducting a high volume of blood collection procedures for diagnostic testing, medical screenings, and patient care.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.